Company Snapshot
10 Sylvan Way
Parsippany, NJ 07054
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 13,800
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$4,618,000,000
$5,473,000,000
$5,626,000,000
Operating Income
$2,269,000,000
$2,803,000,000
$2,928,000,000
Net Income
$1,638,000,000
$2,037,000,000
$2,114,000,000
2020
Gross Profit
$4,618,000,000
Operating Income
$2,269,000,000
Net Income
$1,638,000,000
2021
Gross Profit
$5,473,000,000
Operating Income
$2,803,000,000
Net Income
$2,037,000,000
2022
Gross Profit
$5,626,000,000
Operating Income
$2,928,000,000
Net Income
$2,114,000,000
The above data on Zoetis Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Director and Chief Executive Officer
$2,514,000
$11,199,807
$289,733
$14,003,540
$14,003,540
Director and Chief Executive Officer
Executive Vice President and Group President,U.S. Operations, Global Diagnostics and BioDevices
$725,000
$2,772,211
$136,359
$3,633,570
$3,633,570
Executive Vice President and Group President,U.S. Operations, Global Diagnostics and BioDevices
Executive Vice President Chief Accounting Officer and Chief Financial Officer
$1,159,900
$2,299,689
$95,448
$3,555,037
$3,555,037
Executive Vice President Chief Accounting Officer and Chief Financial Officer
Executive Vice President General Counsel, Corporate Secretary and Lead of Human Health Diagnostics
$929,265
$1,324,655
$106,682
$2,360,602
$2,360,602
Executive Vice President General Counsel, Corporate Secretary and Lead of Human Health Diagnostics
Executive Vice President Chief Digital Officer and Chief Technology Officer and Group President for China, Brazil and Precision Animal Health
$963,600
$1,099,895
$114,561
$2,178,056
$2,178,056
Executive Vice President Chief Digital Officer and Chief Technology Officer and Group President for China, Brazil and Precision Animal Health
Zoetis Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us